Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta.
about
MCP-1 upregulates amylin expression in murine pancreatic β cells through ERK/JNK-AP1 and NF-κB related signaling pathways independent of CCR2Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression.A phase 1-2, prospective, double blind, randomized study of the safety and efficacy of Sulfasalazine for the treatment of progressing malignant gliomas: study protocol of [ISRCTN45828668].Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and TherapyDrugs to block cytokine signaling for the prevention and treatment of inflammation-induced preterm birthInhibition of human telomerase reverse transcriptase by nonsteroidal antiinflammatory drugs in colon carcinomaPomegranate flower: a unique traditional antidiabetic medicine with dual PPAR-alpha/-gamma activator propertiesNuclear factor-kappa B activation in human testicular apoptosisDevelopment of sulfasalazine resistance in human T cells induces expression of the multidrug resistance transporter ABCG2 (BCRP) and augmented production of TNFalphaRole of IKK/NF-κB signaling in extinction of conditioned place aversion memory in ratsTL-118 and gemcitabine drug combination display therapeutic efficacy in a MYCN amplified orthotopic neuroblastoma murine model--evaluation by MRINF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy targetColorectal Cancer and Dysplasia in Inflammatory Bowel Disease: A Review of Disease Epidemiology, Pathophysiology, and Management.Activation of NF-κB in basolateral amygdala is required for memory reconsolidation in auditory fear conditioningImmune modulation with sulfasalazine attenuates immunopathogenesis but enhances macrophage-mediated fungal clearance during Pneumocystis pneumonia.Pneumocystis carinii activates the NF-kappaB signaling pathway in alveolar epithelial cells.Real-time monitoring of nuclear factor kappaB activity in cultured cells and in animal models.Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete?Inhibition of nuclear factor kappa-B signaling reduces growth in medulloblastoma in vivo.Iridoid glycosides fraction of Folium syringae leaves modulates NF-κB signal pathway and intestinal epithelial cells apoptosis in experimental colitis.Protein degradation by ubiquitin-proteasome system in formation and labilization of contextual conditioning memory.Resveratrol differentially modulates inflammatory responses of microglia and astrocytesTNF-α acutely upregulates amylin expression in murine pancreatic beta cells.Treatment of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with mesalazine.Anti-inflammatory effects of Rubus coreanus Miquel through inhibition of NF-κB and MAP Kinase.Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor-kappaB.Recent advances in understanding NF-kappaB regulation.TNF inhibition as therapy for rheumatoid arthritis.The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studiesThe immunologic effects of mesalamine in treated HIV-infected individuals with incomplete CD4+ T cell recovery: a randomized crossover trialMelatonin reduces inflammatory injury through inhibiting NF-kappaB activation in rats with colitis.Molecular mechanisms of sulfasalazine-induced T-cell apoptosisTreating rheumatic patients with a malignancy.NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cellsThe Synergic Anti-inflammatory Impact of Gleditsia sinensis Lam. and Lactobacillus brevis KY21 on Intestinal Epithelial Cells in a DSS-induced Colitis Model.Regulation of apoptosis during homeostasis and disease in the intestinal epithelium.Sulfasalazine Treatment Suppresses the Formation of HLA-B27 Heavy Chain Homodimer in Patients with Ankylosing Spondylitis.Shh and p50/Bcl3 signaling crosstalk drives pathogenesis of BCCs in Gorlin syndrome.NF-kappa B as a target for cancer therapy.Sulfasalazine blocks the development of tactile allodynia in diabetic rats.
P2860
Q21135461-1093DFB7-CE7D-4979-80E3-7E7D25971F28Q24536188-465BDDE8-6CCD-4EFB-A5E1-2BA482E0F17CQ25257862-90C208FD-A7BC-4A30-A158-8E2041F8ABDDQ26740191-329CF85A-F44D-491E-9576-17DE341E732DQ28081049-6496401C-CAA7-472B-95A1-50A66AB6E185Q28194715-C40D9560-F89F-4996-8A5E-CFD89A5DCCF3Q28261771-9143EE80-12E4-4506-81BE-D94E54F7228DQ28344806-4405EC3A-055D-4291-9CDF-1C36EF9DF122Q28394197-E317C837-760F-47CA-872F-5C93C2F7B838Q28480639-4E5CF5CE-B643-415E-A91B-E8C64BDACFF8Q28540575-D16A859F-6C69-4BE5-BE02-070336E02CA0Q28611413-D4256BCA-98BB-4515-9D48-6E64970684ECQ30245054-A85E99C2-FADB-4FA3-AFBD-6D2CE8C1384EQ30463875-096FE069-0309-4707-9710-8F4FED3F8F8DQ33680480-F4A65CE2-ABDF-4D33-B95D-ADC2B8A89D3FQ33768874-97873481-BAE7-4950-9269-1A294A9B8A5BQ33795121-8045C186-7A17-4972-9B37-663B44C629A9Q33868970-644BA5BC-B434-4BEB-B1CE-FCCE90DE37C5Q33872837-DD427140-8C37-429F-82D7-4887B82012BAQ34024008-DB90384B-87B8-4698-8CF9-D43F46372F94Q34067424-C2255B7E-70C4-4C94-A1FC-73FA8191B437Q34114119-BE47D525-3A5A-40A3-A665-BF232B12CF1DQ34152418-E2351595-0351-4DB9-BF58-9A287D80E16DQ34182017-06A3844A-0996-4E67-8B3F-6D78949AF3BEQ34347866-0640DEA3-3153-4868-BBB6-6F17FAAAE4E7Q34543666-64962750-82EF-4845-980F-15C6A2B7C598Q34616595-9D24B076-556A-4FE3-8586-78892EC76468Q34706986-62289686-AF41-4B46-B5FC-F20F6F903816Q34772160-C1C521EB-1D50-49FB-9BDF-621040DBD3F4Q34818798-5E980112-9F9C-47A8-A594-707A40A50603Q34894637-BC1D2C28-9415-4403-B21A-B0E58A0D5A4CQ35044669-17422C85-DBA1-4567-8C68-ABB936050BCCQ35557863-31AD5944-26CA-46EB-AE12-AADAF9D6A841Q35872462-B6F6F991-3427-4B7D-910C-18CA5B48BD67Q36349810-B14C25F4-4F3B-4ED0-8E42-C04A933ACAFFQ36467014-B0C2F0B5-B12A-44EB-9032-1EDE9A42DEBAQ36512479-3E87CF85-F442-49BA-A110-175B54443ACFQ36546794-98D1E832-DA2C-4B8B-8040-340A87C41448Q36709532-790200F6-2247-46B2-9B6D-185B6254D4CCQ36906408-C46EEC68-CFAC-49B5-B8E3-2BA7E60C879E
P2860
Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Suppression of NF-kappaB activ ...... kappaB kinases alpha and beta.
@en
type
label
Suppression of NF-kappaB activ ...... kappaB kinases alpha and beta.
@en
prefLabel
Suppression of NF-kappaB activ ...... kappaB kinases alpha and beta.
@en
P2093
P356
P1433
P1476
Suppression of NF-kappaB activ ...... kappaB kinases alpha and beta.
@en
P2093
P304
P356
10.1053/GAST.2000.19458
P407
P577
2000-11-01T00:00:00Z